Abstract
Humoral immunity develops in the spleen during blood-stage Plasmodium infection. This elicits parasite-specific IgM and IgG, which control parasites and protect against malaria. Studies in mice have elucidated cells and molecules driving humoral immunity to Plasmodium, including CD4+ T cells, B cells, interleukin (IL)-21 and ICOS. IL-6, a cytokine readily detected in Plasmodium-infected mice and humans, is recognized in other systems as a driver of humoral immunity. Here, we examined the effect of infection-induced IL-6 on humoral immunity to Plasmodium. Using P. chabaudi chabaudi AS (PcAS) infection of wild-type and IL-6−/− mice, we found that IL-6 helped to control parasites during primary infection. IL-6 promoted early production of parasite-specific IgM but not IgG. Notably, splenic CD138+ plasmablast development was more dependent on IL-6 than germinal centre (GC) B-cell differentiation. IL-6 also promoted ICOS expression by CD4+ T cells, as well as their localization close to splenic B cells, but was not required for early Tfh-cell development. Finally, IL-6 promoted parasite control, IgM and IgG production, GC B-cell development and ICOS expression by Tfh cells in a second model, Py17XNL infection. IL-6 promotes CD4+ T-cell activation and B-cell responses during blood-stage Plasmodium infection, which encourages parasite-specific antibody production.
Original language | English |
---|---|
Article number | e12455 |
Journal | Parasite Immunology |
Volume | 39 |
Issue number | 10 |
Early online date | 17 Aug 2017 |
DOIs | |
Publication status | Published - Oct 2017 |
Bibliographical note
Funded by Australian National Health & Medical Research Council. Grant Numbers: 1028634, 1028641 University of Queensland Centennial and IPRS ScholarshipsKeywords
- animal model
- B lymphocyte
- CD4 T lymphocyte
- costimulatory molecules
- cytokine
- humoral immunity
- malaria